Literature DB >> 21651323

New drug delivery options for migraine.

Michail Vikelis, Alan M Rapoport.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21651323     DOI： 10.1586/ern.11.62

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN： 1473-7175            Impact factor:   4.618


× No keyword cloud information.
  2 in total

Review 1.  The iontophoretic transdermal system formulation of sumatriptan as a new option in the acute treatment of migraine: a perspective.

Authors:  Michail Vikelis; Konstantinos C Spingos; Alan M Rapoport
Journal:  Ther Adv Neurol Disord       Date:  2015-07       Impact factor: 6.570

2.  Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraine.

Authors:  Michail Vikelis; Dimos D Mitsikostas; Alan M Rapoport
Journal:  Neuropsychiatr Dis Treat       Date:  2012-09-26       Impact factor: 2.570
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.